| Record ID | talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:484841920:635 |
| Source | Talis |
| Download Link | /show-records/talis_openlibrary_contribution/talis-openlibrary-contribution.mrc:484841920:635?format=raw |
LEADER: 00635nam a2200169 a 4500
001 0f598f9f95584b9a8d1a736e500e2dbe
003 UK-BiTAL
005 20050705121852.0
008 930813|||||||||xxu b o000 ||eng|d
020 $a0160379865
035 $a()0160379865
040 $aQU$cQU$dUK-BiTAL
110 1 $aUnited States.$bCongress.$bOffice of Technology Assessment.
245 00 $aCystic fibrosis and DNA tests$h[microfiche] :$bimplications of carrier screening /$cOffice of Technology Assessment.
260 $aWashington, D.C. :$bGovernment Publishing Office,$c1992.
300 $a4 microfiche (309 fr) :$bill. ;$c11 x 15 cm.
500 $aPB92-216142.